BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2023 6:13:55 AM | Browse: 156 | Download: 594
 |
Received |
|
2023-06-20 07:29 |
 |
Peer-Review Started |
|
2023-06-20 07:29 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-07-07 07:17 |
 |
Revised |
|
2023-07-12 03:56 |
 |
Second Decision |
|
2023-08-07 09:26 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2023-10-08 03:24 |
 |
Articles in Press |
|
2023-10-08 03:24 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-11-07 03:18 |
 |
Publish the Manuscript Online |
|
2023-11-14 06:13 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Basic Study |
Article Title |
Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yu-Juan Wang, Yan-Li Wang, Xiao-Fan Jiang and Juan-E Li |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Natural Science Basic Research Plan in the Shaanxi Province of China |
2021JM-549 |
The Plan Project of Shaanxi Provincial Administration of Traditional Chinese Medicine |
2021-ZZ-JC011 |
The Second Youth Science and Technology Talents Project of Shaanxi Provincial Administration of Traditional Chinese Medicine |
2023-ZQNY-017 |
|
Corresponding Author |
Juan-E Li, MD, Associate Chief Physician, Department of Chinese Medicine, Shaanxi Provincial People’s Hospital, No. 256 Youyi West Road, Beilin District, Xi’an 710068, Shaanxi Province, China. lizhuan-1980@126.com |
Key Words |
Jiawei Jiaotai pill; Diabetic cardiomyopathy; Mechanism of action; Enrichment analysis; Network pharmacology; Molecular docking |
Core Tip |
Jiawei Jiaotai Pill is composed of Rhizoma Coptidis, Cinnamon, Radix Astragali, and Puerariae Lobatae Radix. It is mainly used to treat disharmony between the heart and kidneys, insomnia, sore mouth, and the tongue. It is often used to improve apoptosis, increase insulin secretion, and improve blood sugar tolerance. However, there are no reports on the mechanism of Jiawei Jiaotai Pills in the treatment of diabetic cardiomyopathy. We used the network pharmacology method, starting from the drug target, focused on analyzing the biological processes and conducting enrichment analysis of the important targets, and used molecular docking technology to verify the results. |
Publish Date |
2023-11-14 06:13 |
Citation |
Wang YJ, Wang YL, Jiang XF, Li JE. Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology. World J Diabetes 2023; 14(11): 1659-1671 |
URL |
https://www.wjgnet.com/1948-9358/full/v14/i11/1659.htm |
DOI |
https://dx.doi.org/10.4239/wjd.v14.i11.1659 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345